Human CD37 Full Length Protein, His,Flag Tag (Detergent)

Customer Reviews
Cat. No. / Size
Price
Qty
CD7-H52D3-20ug
$805.00
CD7-H52D3-100ug
$2985.00
CD7-H52D3-500ug
$7480.00
ETA of in-stock products:2 business days

Product Details

  • Application

    1. Immunization
    2. Affinity testing (SPR / BLI)
    3. Screening (ELISA)
  • Synonyms

    CD37, Tspan-26, TSPAN26

  • Source

    Detergent Human CD37 Full Length Protein, His,Flag Tag (CD7-H52D3) is expressed from human 293 cells (HEK293). It contains AA Met 1 - Arg 281 (Accession # P11049).

    Predicted N-terminus: Met 1

    Request for sequence
  • Molecular Characterization

    CD37 Structure

    Other Tags and Version Biotin & Other Labeled Version

    This protein carries a polyhistidine tag at the C-terminus, followed by a Flag tag. The protein has a calculated MW of 50.4 kDa.

    *The DDM/CHS buffer (Cat. No. DC-11) is sold separately and not included in protein, you can follow the link for product information.

    1. Structure

      Each full-length transmembrane protein is encapsulated by detergent micelle.

    2. Synthesis Process

      Through mild detergent micelle extraction, dedicated solubilization, and stringent affinity purification, we maximally retain the native transmembrane conformation of full-length transmembrane proteins throughout downstream purification. This workflow yields purified, detergent-solubilized proteins free of unrelated membrane impurities and exogenous scaffold proteins, with exceptional purity, accurate quantitation, and well-preserved biological activity—ideal for immunization, binding assays in antibody discovery and screening (ELISA) and affinity testing (SPR and BLI), etc.

  • Endotoxin

    Less than 1.0 EU per μg by the LAL method / rFC method.

  • Purity

    >90% as determined by SDS-PAGE.

  • Formulation

    This product is not suitable for cell based experiments due to cytotoxicity of DDM.
    DDM and CHS are INDISPENSABLE to keep membrane protein soluble and active, under no circumstances should you remove DDM and CHS.
    DDM/CHS buffer (DC-11) is sold separately and not included in protein, and please contact us if you need the buffer.
    If glycerol is not compatible with your application, remove glycerol just before the immediate experiment, and NEVER store glycerol-free protein solution.

    Supplied as 0.2 μm filtered solution in 50 mM HEPES, 150 mM NaCl, DDM, CHS, pH7.5 with glycerol as protectant.

    Contact us for customized product form or formulation.

  • Shipping

    This product is supplied and shipped with dry ice, please inquire the shipping cost.

  • Storage

    Please avoid repeated freeze-thaw cycles.

    This product is stable after storage at:

    1. The product MUST be stored at -70°C or lower upon receipt;
    2. -70°C for 3 months under sterile conditions.
  • ACRO Quality Management System

    1. QMS(ISO, GMP)
    2. Quality Advantages
    3. Quality Control Process

Customers Also Viewed

Performance Data

  • Bioactivity-ELISA

     CD37 ELISA

    Immobilized Human CD37 Full Length Protein, His,Flag Tag (Cat. No. CD7-H52D3) at 1 μg/mL (100 μL/well) can bind Anti-CD37 antibody (Naratuximab) with a linear range of 0.1-2 ng/mL (QC tested).

    Protocol
  • Bioactivity-SPR

     CD37 SPR

    Anti-CD37 antibody (Naratuximab) captured on Protein A Chip can bind Human CD37 Full Length Protein, His,Flag Tag (Cat. No. CD7-H52D3) with an affinity constant of 20.3 nM as determined in a SPR assay (in presence of DDM and CHS) (Biacore 8K) (Routinely tested).

    Protocol

Customer Reviews
Writing Reviews

Background

A tetraspanin protein highly restricted to the B-cell lineage and a validated target in B-cell malignancies. CD37 modulates integrin signaling and cell adhesion. Therapeutics include antibody-drug conjugates (naratuximab emtansine) and CAR-T cells designed to treat Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia.

Recent Advances

 
Drug Development Progress
  • English Name:

    Leukocyte antigen CD37

  • Category:

  • Approved Drugs:

    0 Details

  • Drugs in Clinical Trials:

    8 Details

  • Highest Development Stage:

    Phase 2 Clinical

Contact Us
Drug Candidate Licensing
More
  • Basic Product Information
  • Product Details
  • Customers Also Viewed
  • Performance Data
  • Customer Reviews
  • Background
Contact Us

전화
글로벌: +1 800-810-0816 (무료)
아시아태평양: +86 400-682-2521

주소 서울특별시 송파구 법원로11길 11, 제3층 제비-314,315호